Perficient: Drug Development

FEBRUARY 22, 2024

Several books have been written on the concept, and many more refer to it when discussing differentiation and disruption within marketing and product development. It’s common that people view novel and innovative, first-to-market groups as having great ideas. The analogy of the “red ocean” of a saturated market drives home his point.

Marketing 116

Marketing Production Government Regulations 116

Drug Target Review

AUGUST 14, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Engineering 59

Engineering Science Drugs Research 59

Drug Target Review

JUNE 20, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 64

Science Research Marketing Drugs 64

Drug Target Review

JULY 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Clinical Trials 59

Clinical Trials Science Research Trials 59

PLOS: DNA Science

JUNE 13, 2024

Through graphics and five main points, Chan countered the wet market scenario of the pandemic’s beginnings. The evidence supporting viral origin at the Huanan seafood market was never compelling – it just seemed possible. c) in a “wet market?” Her points: 1. An altered virus could have escaped.

Virus 52

Virus RNA DNA Science 52

Common Sense for Drug Policy Blog

JANUARY 5, 2024

Part of this 'performance' has to do with adapting to the different temporal demands of the labor market—in other words, the management of sleep and wakefulness. In the current 'gig economy' — dominated by those jobs in which people are paid by the task, rather than receiving a fixed salary — work never stops. As Crary ( 2013 , p.

Pharmacy 52

Pharmacy Regulations Production Marketing 52

Drug Target Review

SEPTEMBER 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Government 59

Government Science Research Drugs 59

Drug Target Review

NOVEMBER 30, 2023

On my return to Europe, I took a position at Nestlé as Head of the Research Centre, where I led the scientific development of several highly innovative health promoting food products from laboratory to market. Then I was approached to co-found AC Immune in 2003. billion plus additional royalties.

Disease 95

Disease Therapies Laboratories Treatment 95

Perficient: Drug Development

OCTOBER 3, 2023

Bill Davis Senior Vice President, Marketing & Alliances As senior vice president of marketing and alliances, Bill Davis is responsible for Perficient’s global marketing and communications functions. Bill has led marketing at Perficient since 2003, in a period of intense growth.

Engineering 52

Engineering Marketing Production 52

Drug Target Review

MAY 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

RNA 59

RNA DNA Bioinformatics Science 59

Drug Target Review

JUNE 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 69

Science Engineering Research Drugs 69

Drug Target Review

OCTOBER 14, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 52

Science Pharmaceutical Companies Drug Development Pharmaceuticals 52

Drug Target Review

SEPTEMBER 13, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Science 59

Science Research Marketing Drugs 59

Drug Target Review

OCTOBER 24, 2024

As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge.

Cell Based Assays 52

Cell Based Assays Science Disease Doctors 52

The Pharma Data

OCTOBER 21, 2020

Founded in 2003, Athenex, Inc. To participate in the call, dial 877-407-0784 (domestic) or 201-689-8560 (international) fifteen minutes before the conference call begins and reference the conference passcode 13711719. About Athenex, Inc.

Engineering 52

Engineering Therapies Treatment International 52

FDA Law Blog: Biosimilars

AUGUST 29, 2024

3582 went nowhere; and many additional unsuccessful attempts to get a similar bill passed followed over the years. But like cockroaches, some pieces of legislation are resilient and never seem to die. And like its predecessor bills, S. 142 includes narrow exceptions: (B) Exception.

Biosimilars 57

Biosimilars Licensing Licensing Production 57

The Pharma Data

SEPTEMBER 8, 2021

For example, in 2001 with anthrax and 2003 with SARS-CoV1, TIB Molbiol demonstrated their ability to develop PCR assays for the detection of new pathogens within days. TIB Molbiol is a biotech company that has supplied the global market with reagents for research and medical diagnostics for over 30 years. About TIB Molbiol.

Virus 52

Virus Assay Development Disease Research 52

The Pharma Data

JANUARY 25, 2021

The company was founded in 2003 based on innovative research from Uppsala University , Sweden. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and outlicensing potential.

Pharmaceutical Companies 40

Pharmaceutical Companies Disease Treatment Pharmaceuticals 40

The Pharma Data

JANUARY 18, 2021

The company’s common shares are listed on the Euronext Growth Paris market (Ticker: ALBPS -ISIN: FR0012816825). The company is based in Paris, France, and Cambridge, Massachusetts. Disclaimer This press release contains forward-looking statements. Forward-looking statements include all statements that are not historical facts.

Regulations 40

Regulations Clinical Trials Production Disease 40

Agency IQ

APRIL 8, 2024

Since these issues could occur during the investigational phase of clinical development as well as in the post-marketing setting—and product status could very well differ by country/region—ICH members determined that these guidelines should be developed to facilitate the exchange of information in both settings.

FDA 40

FDA Production Regulations Vaccine 40

FDA Law Blog: Biosimilars

SEPTEMBER 19, 2023

The closest FDA has come is in a 2003 preamble noting that patents that claim finished dosage forms—which can include “metered aerosols, capsules, metered sprays, gels, and pre-filled drug delivery systems”—should be listed in the Orange Book, suggesting that a patent that claims both the drug substance and the delivery device should be listed.

FDA 104

FDA Biosimilars Drugs FDA Approval 104

The Pharma Data

JANUARY 26, 2021

The company was founded in 2003 based on innovative research from Uppsala University , Sweden. The project portfolio is a combination of fully funded projects run in partnership with global pharmaceutical companies and innovative in-house projects with significant market and out-licensing potential.

Disease 40

Disease Pharmaceutical Companies Treatment Licensing 40

The Pharma Data

MARCH 13, 2021

Fei-Fei Li (44), a leading expert in artificial intelligence and Professor in the Computer Science Department at Stanford University in California, and Alberto Weisser (65), a renowned agricultural expert with decades of capital market experience in the United States. Li and Weisser are intended to succeed Johanna W.

International 52

International Engineering Science Marketing 52

The Premier Consulting Blog

JANUARY 17, 2023

The Pediatric Research Equity Act (PREA) was signed into law in 2003 to increase pediatric use information in product labeling and close knowledge gaps regarding the safety, efficacy, and appropriate dosing of drugs to treat children.

Production 52

Production FDA Clinical Trials Compliance 52

Perficient: Drug Development

JANUARY 25, 2024

This is a disappointing reversal for payers, as the 2010 results showed a nine-point gain compared to the 2003 figure. consumers shows health insurance companies declined 11 percentage points among respondents rating their experience “Excellent” or “Good.” But the 2023 results now put payers two points below where they stood 20 years prior.

Nurses 52

Nurses Health Insurance Companies Pharmaceutical Companies Hospitals 52

FDA Law Blog: Biosimilars

FEBRUARY 27, 2024

. § 156 and interpretive case law, if an applicant for patent term extension has multiple NDA approvals of a product, PTE applicant can only rely on ‘a’ (single) regulatory review period for a first permitted commercial marketing or use of a product to establish the requirements for patent term extension. 2003) , and Biogen lnt’l v.

FDA Approval 57

FDA Approval FDA Production Therapies 57

The Pharma Data

NOVEMBER 11, 2020

departing in 2003 to become the chief scientific officer for Tapestry Pharmaceuticals and ChromaDex Inc. He attributes his success to good fortune and hard work, and hopes to see some of his patented compounds gain approval and reach market readiness in the coming years. In 2009, he established Ironstone Separations Inc.,

Organic Chemistry 52

Organic Chemistry Science Pharmacy Pharmaceuticals 52

Drug Channels

FEBRUARY 23, 2021

For background, see Express Scripts + Prime Therapeutics: Our Four Takeaways From This Market Changing Deal. Dave Marley has just sold Marley Drug, the independent pharmacy he founded in 2003, to Medicure Pharma. Re: UnitedHealthcare Coverage Policies , American Hospital Association. The battle for specialty drug margin rages on.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Independent Pharmacies 52

The Pharma Data

OCTOBER 19, 2020

Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. Nanobiotix is listed on the regulated market of Euronext in Paris (Euronext: NANO / ISIN: FR0011341205; Bloomberg: NANO: FP).

Clinical Trials 52

Clinical Trials Immune Response Trials Therapies 52

The Pharma Data

NOVEMBER 4, 2020

From 2003 to 2014, Mr. Thoresen was the managing director of Nycomed Pharma AS acquired by Takeda Pharmaceutical Company Limited in 2011 as part of an acquisition transaction with a total value of approximately USD $14B. XPhyto Therapeutics Corp. XPhyto Therapeutics Corp.: Hugh Rogers, CEO and Director.

Pharmaceutical Companies 40

Pharmaceutical Companies International Pharmaceuticals Production 40

BMG Labtech

OCTOBER 4, 2023

Next-generation sequencing technologies The number of options for researchers looking for sequencing instruments has increased significantly in recent years and represents a rapidly changing and increasingly competitive market. The MiSeq was launched in 2011 and is the oldest next-generation sequencing sequencer on the market.

DNA 52

DNA RNA Bioinformatics Research 52

Codon

SEPTEMBER 8, 2024

deaths per 100,000 women in 2003 to close to 1 per 100,000 in 2020. If your job is creating shoes from start to finish, it’s fairly straightforward to measure productivity: it’s merely the dollar value of the shoes you make each year based on market prices. Just consider the U.S.

Production 101

Production Engineering Science Research 101

The Pharma Data

DECEMBER 15, 2020

Klisyri will be manufactured by Athenex, highlighting the vertically integrated capabilities of the company ranging from a preclinical lead to a developed product for market launch. Mr. Peter Guenter, CEO of Almirall, stated, “We are delighted to partner with Athenex to market Klisyri in the U.S. Founded in 2003, Athenex, Inc.

FDA Approval 52

FDA Approval FDA Treatment Small Molecule 52

The Pharma Data

NOVEMBER 9, 2020

About NANOBIOTIX: www.nanobiotix.com Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell.

Immune Response 40

Immune Response Therapies Clinical Trials Treatment 40

The Pharma Data

MARCH 26, 2021

The CHMP opinion is one of the final steps in the marketing authorisation procedure prior to approval by the European Commission. If approved, Benlysta would become the first and only biologic approved for both Systemic Lupus Erythematosus (SLE) and LN in the European Union. About lupus nephritis.

Therapies 52

Therapies Treatment Disease Vaccine 52

The Pharma Data

AUGUST 19, 2021

Under Mr. Gorsky’s leadership, the Company has delivered exceptional financial performance, with its market capitalization growing from nearly $180 billion to more than $470 billion as the share price increased over 170%. “I

Pharmaceuticals 52

Pharmaceuticals Vaccine International Government 52

The Pharma Data

FEBRUARY 25, 2021

Pfizer’s TBE vaccine, marketed under the brand names TicoVac and FSME-Immun in Europe, is an inactivated whole virus vaccine developed using a master ‘seed’ virus that is similar to the TBE virus found in nature. 2003 Dec 12;22(2):217-23. About TicoVac (TBE vaccine, whole virus inactivated). 2011;29(43):7307-19. Ehrlich HJ, et al.

FDA 52

FDA Vaccine Virus Clinical Trials 52